This Notice of Funding Opportunity (NOFO) supports studies establishing deeper mechanistic insights and causal cellular and molecular relationships between TDP-43 pathology and phenotypic outcomes. Additionally, it requires comparisons between at least two TDP-43 proteinopathies, one of which must be an Alzheimer’s Disease Related Dementia (ADRD), such as, but not limited to, Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), with or without Alzheimer’s disease neuropathological change (AD-NC), or Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), to further understand distinct and overlapping mechanisms in these syndromes and what is causally involved in cognitive decline and dementia.
Application Due Dates: June 4, 2024; Oct. 4, 2024
PAR-24-148 Expiration Date October 05, 2024
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Oct 04, 2024
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.